Misinformed, misconducted, misguided and misrepresented meta-analyses. The use of antidepressants (AD) in major depressive disorders (MDD)
- PMID: 32090411
- DOI: 10.1111/bdi.12893
Misinformed, misconducted, misguided and misrepresented meta-analyses. The use of antidepressants (AD) in major depressive disorders (MDD)
Keywords: antidepressants; depression; meta-analyses.
Comment on
-
Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis.BMC Psychiatry. 2017 Feb 8;17(1):58. doi: 10.1186/s12888-016-1173-2. BMC Psychiatry. 2017. PMID: 28178949 Free PMC article.
References
REFERENCES
-
- Jakobsen JC, Katakam KK, Schou A, et al. Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and trial sequential analysis. BMC Psych. 2017;17:58.
-
- Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391:1357-1366.
-
- Hieronymus F, Emilsson JF, Nilsson S, Eriksson E. Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression. Mol Psych. 2016;21:523-530.
-
- Osler M, Wium-Andersen MK, Wium-Andersen IK, et al. Incidence of suicidal behaviour and violent crime folowing antodepressant medication: a Danish cohort study. Acta Psychiatr Scand. 2019;1-10.
-
- Munkholm K, Paludan AS, Boesen K. Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis. BMJ Open. 2019;9:e024886.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
